Role of ErbB2 in selection for adjuvant tamoxifen or aromatase inhibitors.Mr J Michael DixonWomen's health2008Evaluation of: Rasmussen BB, Regan MM, Lykkesfeldt AE et al.: Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early… (More)